Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs

Novartis AG will share the risks and rewards as Amgen Inc. will help develop its pipeline of experimental Alzheimer’s disease drugs.

Popular Posts


EOF

(Visited 4 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami